Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 5 % of short-term debt in 2026; threshold 65 %.
Financials
Financial year 2026
VERBO PHARMA from Rotselaar, company number BE0898012142, closed financial year 2026 with a result of € 10,886 after tax. For that financial year VERBO PHARMA recorded a gross margin of € 22,676 and equity of € 789,198. Compared with financial year 2025, the result moved from € 27,348 to € 10,886. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 28, 2026.
€ 789,198
▲ 1% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 10,886
▼ 60% vs 2025
Profit after tax over the fiscal year.
€ 4,924
▲ € 3,857 vs 2025
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € 645,598.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 471
▼ 96% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 7,955
▲ 13% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 45,118 | € 43,549 | € 43,890 | € 22,676 | ▼ 48% |
| Profit after taxes | € 27,563 | € 26,152 | € 27,348 | € 10,886 | ▼ 60% |
| Equity | € 724,812 | € 750,964 | € 778,312 | € 789,198 | ▲ 1% |
| Total debts | € 217,941 | € 190,273 | € 155,513 | € 151,509 | ▼ 3% |
| Cash | € 9,994 | € 8,206 | € 1,067 | € 4,924 | ▲ € 3,857 |
| Retained profit | € 581,212 | € 607,364 | € 634,712 | € 645,598 | ▲ 2% |
| Bank debt | € 73,487 | € 36,954 | € 0 | € 0 | |
| Balance sheet total | € 942,753 | € 941,237 | € 933,826 | € 940,708 | ▲ 1% |
Key figures of VERBO PHARMA, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
What happened to VERBO PHARMA?
What happened at VERBO PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 10,886 (▼ 60% vs 2025). Source: NBB ↗
- New establishment in Leuven. KBO
- Start of the company according to the CBE. KBO
In short
From € 27,563 profit in 2023 to € 10,886 profit in 2026.
Paid € 35,931 in corporate taxes since 2023.
Best year ever: 2023, with € 27,563 profit.
A new publication or filing at VERBO PHARMA? We notify you, reason included.
Follow VERBO PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind VERBO PHARMA are Jos Bombeek and Els Vermeulen. It owns 100% of Apotheek Tempelhof itself.
Directors
According to the 2026 annual accounts
Els Vermeulen
Director
Establishments
Establishment units
Physical locations of this company
Lostingstraat 6
3110 Rotselaar
Acht-Meistraat 32
3018 Leuven
Active since 13 May 2008
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0898.012.142
- VAT number
- BE 0898.012.142
- Registered office
- Lostingstraat 6, 3110 Rotselaar
- Names & denominations
- VERBO PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 May 2008
- Peppol
- Active · Active since 2 Jan 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Activiteiten van holdings
Holdings